Cochrane Reviews
| Status | Stage |
|---|---|
- Acellular dermal matrices for breast reconstruction surgery
- Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
- Antitumour antibiotic containing regimens for metastatic breast cancer
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
- Axillary treatment for operable primary breast cancer
- Benzo-pyrones for reducing and controlling lymphoedema of the limbs
- Bisphosphonates and other bone agents for breast cancer
- Body weight management in overweight and obese breast cancer survivors
- Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis
- Breast surgery for metastatic breast cancer
- Cancer genetic risk assessment for individuals at risk of familial breast cancer
- Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
- Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients
- Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
- Combination versus sequential single agent chemotherapy for metastatic breast cancer
- Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy
- Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
- Different types of implants for reconstructive breast surgery
- Exercise for women receiving adjuvant therapy for breast cancer
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment
- Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery
- Follow-up strategies for women treated for early breast cancer
- Fulvestrant for hormone-sensitive metastatic breast cancer
- High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
- High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
- Home-based multidimensional survivorship programmes for breast cancer survivors
- Hypofractionated radiation therapy for early breast cancer
- Immediate versus delayed reconstruction following surgery for breast cancer
- Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer
- Implants versus autologous tissue flaps for breast reconstruction following mastectomy
- Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction
- Interventions for raising breast cancer awareness in women
- Interventions for reducing the use of opioids in breast reconstruction
- Interventions for relieving the pain and discomfort of screening mammography
- Intraoperative sub-areolar frozen section analysis for detecting nipple involvement in candidates for nipple-sparing mastectomy
- LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
- Localization techniques for guided surgical excision of non-palpable breast lesions
- Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review
- Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
- Manual lymphatic drainage for lymphedema following breast cancer treatment
- Methods of communicating a primary diagnosis of breast cancer to patients
- Mindfulness-based stress reduction for women diagnosed with breast cancer
- Multidisciplinary rehabilitation for follow-up of women treated for breast cancer
- Nipple- and areola-sparing mastectomy for the treatment of breast cancer
- Non-hormonal interventions for hot flushes in women with a history of breast cancer
- Omission of whole breast irradiation for postmenopausal women with early breast cancer
- Oncoplastic breast-conserving surgery for women with primary breast cancer
- Online support groups for women with breast cancer
- Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
- Overdiagnosis due to screening mammography for women aged 40 years and over
- Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery
- PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
- Partial breast irradiation versus whole breast radiotherapy for early breast cancer
- Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery
- Physical activity for women with breast cancer after adjuvant therapy
- Physical therapies for reducing and controlling lymphoedema of the limbs
- Platinum-based chemotherapy for early triple-negative breast cancer
- Platinum-containing regimens for metastatic breast cancer
- Platinum-containing regimens for triple-negative metastatic breast cancer
- Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
- Post-operative radiotherapy for ductal carcinoma in situ of the breast
- Postoperative tamoxifen for ductal carcinoma in situ
- Preoperative chemotherapy for women with operable breast cancer
- Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients
- Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer
- Psychological interventions for women with metastatic breast cancer
- Psychological interventions for women with non-metastatic breast cancer
- Regional analgesia with or without general anaesthesia for breast cancer surgery: a network meta-analysis
- Regular self-examination or clinical examination for early detection of breast cancer
- Risk prediction models for familial breast cancer
- Risk-reducing mastectomy for the prevention of primary breast cancer
- Risk-reducing mastectomy for unaffected women with a strong family history of breast cancer
- Risk-reducing medications for primary breast cancer: a network meta-analysis
- Screening for breast cancer with mammography
- Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer
- Sequencing of chemotherapy and radiotherapy for early breast cancer
- Shared decision-making for supporting women’s decisions about breast cancer screening
- Single agent versus combination chemotherapy for metastatic breast cancer
- Skin-sparing mastectomy for the treatment of breast cancer
- Specialist breast care nurses for support of women with breast cancer
- Strategies for increasing the participation of women in community breast cancer screening
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment
- Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Systemic therapy for treating locoregional recurrence in women with breast cancer
- Taxane-containing regimens for metastatic breast cancer
- Taxanes for adjuvant treatment of early breast cancer
- Timing of breast surgery in premenopausal breast cancer patients
- Toremifene versus tamoxifen for advanced breast cancer
- Training health workers in clinical breast examination for early detection of breast cancer in low- and middle-income countries
- Trastuzumab containing regimens for early breast cancer
- Trastuzumab-containing regimens for metastatic breast cancer
- Tumour bed boost radiotherapy for women after breast-conserving surgery
- Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
- Wound drainage after axillary dissection for carcinoma of the breast
- Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer
- Prevention (4)
- Physical activity (0)
- Breast feeding (0)
- Dietary prevention (0)
- Endocrine prevention (2)
- Prophylactic surgery (2)
- Early detection (9)
- Screening methods (8)
- Mammography (4)
- Interventions for relieving the pain and discomfort of screening mammography
- Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
- Overdiagnosis due to screening mammography for women aged 40 years and over
- Screening for breast cancer with mammography
- Breast self-examination (1)
- Clinical breast examination (2)
- High-risk women (1)
- Mammography (4)
- Participation in screening (1)
- Quality control (0)
- Screening methods (8)
- Diagnosis (2)
- Pathology (2)
- Investigations (0)
- Familial breast cancer (2)
- Communication of information (3)
- DCIS (2)
- Endocrine therapy (1)
- Post-operative radiotherapy (1)
- Chemotherapy (21)
- Early breast cancer (9)
- Adjuvant (6)
- Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
- High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
- Platinum-based chemotherapy for early triple-negative breast cancer
- Sequencing of chemotherapy and radiotherapy for early breast cancer
- Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer
- Taxanes for adjuvant treatment of early breast cancer
- Neoadjuvant (3)
- Adjuvant (6)
- Locally advanced breast cancer (0)
- Advanced breast cancer (11)
- Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
- Antitumour antibiotic containing regimens for metastatic breast cancer
- Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
- Combination versus sequential single agent chemotherapy for metastatic breast cancer
- Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
- High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
- Platinum-containing regimens for metastatic breast cancer
- Platinum-containing regimens for triple-negative metastatic breast cancer
- Single agent versus combination chemotherapy for metastatic breast cancer
- Taxane-containing regimens for metastatic breast cancer
- Locally recurrent breast cancer (1)
- Early breast cancer (9)
- Radiotherapy (6)
- Early breast cancer (6)
- Hypofractionated radiation therapy for early breast cancer
- Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
- Omission of whole breast irradiation for postmenopausal women with early breast cancer
- Partial breast irradiation versus whole breast radiotherapy for early breast cancer
- Sequencing of chemotherapy and radiotherapy for early breast cancer
- Tumour bed boost radiotherapy for women after breast-conserving surgery
- Locally advanced breast cancer (0)
- Advanced breast cancer (0)
- Locoregional recurrence (0)
- Prophylactic radiotherapy (0)
- Early breast cancer (6)
- Endocrine therapy (9)
- Early breast cancer (4)
- Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
- LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Locally advanced breast cancer (1)
- Advanced breast cancer (4)
- Locally recurrent breast cancer (0)
- Early breast cancer (4)
- Targeted therapy (7)
- Early breast cancer (2)
- Locally advanced breast cancer (1)
- Advanced breast cancer (4)
- Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
- Trastuzumab-containing regimens for metastatic breast cancer
- PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
- Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
- Locally recurrent breast cancer (0)
- Breast surgery (20)
- Surgical techniques (9)
- Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery
- Localization techniques for guided surgical excision of non-palpable breast lesions
- Wound drainage after axillary dissection for carcinoma of the breast
- Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery
- Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction
- Interventions for reducing the use of opioids in breast reconstruction
- Skin-sparing mastectomy for the treatment of breast cancer
- Nipple- and areola-sparing mastectomy for the treatment of breast cancer
- Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery
- Reconstruction (7)
- Acellular dermal matrices for breast reconstruction surgery
- Different types of implants for reconstructive breast surgery
- Immediate versus delayed reconstruction following surgery for breast cancer
- Implants versus autologous tissue flaps for breast reconstruction following mastectomy
- Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction
- Oncoplastic breast-conserving surgery for women with primary breast cancer
- Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery
- Timing of surgery (2)
- Choice of treatment modality (2)
- Surgical techniques (9)
- Management of the axilla (3)
- Bisphosphonates (2)
- Treatment-related adverse events and side effects (6)
- Management of chemotherapy-related side effects (3)
- Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients
- Non-hormonal interventions for hot flushes in women with a history of breast cancer
- Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients
- Management of radiotherapy-related side effects (0)
- Other treatment related events (3)
- Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis
- Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Management of chemotherapy-related side effects (3)
- Psychosocial care (5)
- Mindfulness-based stress reduction for women diagnosed with breast cancer
- Online support groups for women with breast cancer
- Psychological interventions for women with metastatic breast cancer
- Specialist breast care nurses for support of women with breast cancer
- Psychological interventions for women with non-metastatic breast cancer
- Lymphoedema (5)
- Benzo-pyrones for reducing and controlling lymphoedema of the limbs
- Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy
- Manual lymphatic drainage for lymphedema following breast cancer treatment
- Physical therapies for reducing and controlling lymphoedema of the limbs
- Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment
- Allied health care (5)
- Exercise for women receiving adjuvant therapy for breast cancer
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment
- Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer
- Physical activity for women with breast cancer after adjuvant therapy
- Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer
- Complementary therapy (4)
- Alternative medicine (systemic) (3)
- Herbal medicine (2)
- Homeopathy (1)
- Other (0)
- Traditional Chinese medicine (0)
- Diet (0)
- Physical therapies (1)
- Acupuncture (1)
- Chiropractic (0)
- Manual therapy (0)
- Massage (0)
- Alternative medicine (systemic) (3)
- Survivorship care (6)
- Follow-up strategies for women treated for early breast cancer
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment
- Home-based multidimensional survivorship programmes for breast cancer survivors
- Multidisciplinary rehabilitation for follow-up of women treated for breast cancer
- Body weight management in overweight and obese breast cancer survivors
- Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer